UNSPSC 51422315: Prednisolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9PHQ9Y1OLM, chemically known as 3,20-dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene but generally known as prednisolone, which bears US NIH Compound Identifier 5755. European Medicines Agency schedules Prednisolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10018MIG.

UNSPSC 51422315 Prednisolone is a Commodity code that designates a single pharmaceutical product — a corticosteroid medication — yet the recent state and local opportunities tagged under it reflect procurement of broader pharmaceutical and health-system products and services that diverge from prednisolone specifically. Seminole County, Florida's IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs, indicate that issuers are using this code to tag pharmaceutical procurement at scale across health departments, county health agencies, and state HHS commissions. The actual buying under this code encompasses emergency pharmaceutical supplies (naloxone for opioid reversal), drug management systems, and strategic pharmacy benefit sourcing — not prednisolone monotherapy.

Recent activity concentrates in Florida and Texas, with Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) gathering vendor capability information on direct-to-manufacturer prescription programs for self-insured health plans. The Seminole County procurement is structured as a fixed-fee IFB with a two-year initial term and one-year renewal option, requiring E-Verify compliance and standard liability insurance; the Texas RFI is an exploratory solicitation preceding formal RFP issuance. Code tagging appears imprecise — neither opportunity targets prednisolone procurement — suggesting procurement offices may be using this commodity code as a catch-all for pharmaceutical-related acquisitions rather than adhering to narrow product classification.